Related Experiment Video
Updated: May 17, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Surgical treatment of chronic thromboembolic pulmonary hypertension
David P Jenkins1, Michael Madani, Eckhard Mayer
1Papworth Hospital, Cambridge, UK. david.jenkins@papworth.nhs.uk
Insights
Chronic thromboembolic pulmonary hypertension (CTEPH) may be more common than previously thought. Pulmonary endarterectomy (PEA) offers the best cure, though surgical expertise is crucial for complex cases.
Area of Science:
- Cardiology
- Thoracic Surgery
- Pulmonary Medicine
Background:
- Chronic thromboembolic pulmonary hypertension (CTEPH) is potentially underdiagnosed.
- Accurate diagnosis and surgical assessment are vital for patient management.
- Operability assessment currently relies heavily on surgical experience due to lack of risk stratification.
Purpose of the Study:
- To review the diagnostic and surgical management of CTEPH.
- To highlight the importance of experienced surgical centers for pulmonary endarterectomy (PEA).
- To discuss the technical aspects and outcomes of PEA.
Main Methods:
- Review of diagnostic imaging for CTEPH operability.
- Description of standard pulmonary endarterectomy (PEA) surgical techniques.
- Discussion of deep hypothermic circulatory arrest in PEA.
- Reference to the PEACOG trial regarding cognitive function post-PEA.
Main Results:
- Pulmonary endarterectomy (PEA) is the primary curative treatment for CTEPH.
- Challenges in PEA include managing distal disease and achieving complete dissection.
- Post-operative complications like reperfusion pulmonary edema can occur.
- In-hospital mortality for PEA is less than 5% at experienced centers.
Conclusions:
- Referral to experienced centers is essential for suspected CTEPH patients.
- PEA, despite its complexity, offers the best chance for cure.
- Continued vigilance for post-operative complications is necessary.
Abstract:
It is likely that chronic thromboembolic pulmonary hypertension (CTEPH) is more prevalent than currently recognised. Imaging studies are fundamental to decision making with respect to operability. All patients with suspected CTEPH should be referred to an experienced surgical centre. Currently, there is no risk scoring stratification system to guide operability assessment and it is predominantly based on surgical experience. The aim of pulmonary endarterectomy (PEA) is the removal of obstructive material to immediately reduce pulmonary vascular resistance. PEA affords the best chance of cure, but is difficult to perfect. Recognition and clearance of distal segmental and subsegmental disease is the main problem. The basic surgical techniques include: median sternotomy incision, cardiopulmonary bypass, arteriotomy incisions within pericardium, and a true endarterectomy with meticulous full distal dissection. Deep hypothermic circulatory arrest is recommended as the best means of reducing blood flow in the pulmonary artery to allow a clear field for dissection. In the recent PEACOG (PEA and COGnition) trial there was no evidence of cognitive impairment post-PEA. Reperfusion pulmonary oedema and residual pulmonary hypertension are unique post-operative complications post-PEA and are associated with increased mortality. However, in-hospital mortality is now <5% in experienced centres.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
